Among the other suggestions of the WHO, there was the proposed addition of a footnote on the Agenda I part of the Conference, stating that preparations containing predominantly cannabidiol instead of more than 0.two per cent of delta-nine-tetrahydrocannabinol will not be beneath international Manage